Market Tracker

12/12 5:15pm ET

Biospecifics Technologies Corp (NASDAQ:BSTC)

43.20
Delayed Data
As of 4:00pm ET
 +0.06 / +0.14%
Today’s Change
41.95
Today|||52-Week Range
58.79
-22.44%
Year-to-Date
New Strong Sell Stocks for December 6th
Dec 06 / Zacks.com - Paid Partner Content
New Strong Sell Stocks for December 1st
Dec 01 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close43.14
Today’s open43.12
Day’s range42.63 - 43.86
Volume11,098
Average volume (3 months)24,085
Market cap$309.1M
Data as of 4:00pm ET, 12/12/2017

Growth & Valuation

Earnings growth (last year)+18.18%
Earnings growth (this year)+0.64%
Earnings growth (next 5 years)+38.00%
Revenue growth (last year)+15.39%
P/E ratio27.2
Price/Sales15.45
Price/Book5.49

Competitors

 Today’s
change
Today’s
% change
CLXTCalyxt Inc+1.19+5.23%
CDXSCodexis Inc+0.50+6.94%
ARWRArrowhead Pharmaceut...+0.04+1.14%
AVXLAnavex Life Sciences...-0.10-3.03%
Data as of 4:00pm ET, 12/12/2017

Financials

Next reporting dateMarch 14, 2018
EPS forecast (this quarter)$0.39
Annual revenue (last year)$26.3M
Annual profit (last year)$11.4M
Net profit margin43.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President &
Chief Executive Officer
Thomas L. Wegman
Corporate headquarters
Lynbrook, New York

Forecasts